Get the Stockscreener App
85.57
2.32%
-2.03
After Hours:
85.57
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Citigroup Inc stock is traded at $85.57, with a volume of 18.06M.
It is down -2.32% in the last 24 hours and up +9.34% over the past month.
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
See More
Previous Close:
$87.60
Open:
$87.61
24h Volume:
18.06M
Relative Volume:
1.21
Market Cap:
$145.74B
Revenue:
$81.60B
Net Income/Loss:
$13.38B
P/E Ratio:
13.52
EPS:
6.33
Net Cash Flow:
$-73.96B
1W Performance:
-0.81%
1M Performance:
+9.34%
6M Performance:
+16.80%
1Y Performance:
+32.17%
1-Day Range:
$85.48
$87.79
1-Week Range:
$85.46
$88.83
52-Week Range:
$53.51
$88.83
Citigroup Inc Stock (C) Company Profile
Name
Citigroup Inc
Sector
Industry
Phone
(212) 559-1000
Address
388 GREENWICH STREET, NEW YORK, NY
Compare C with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
C
Citigroup Inc
|
85.57 | 145.74B | 81.60B | 13.38B | -73.96B | 6.33 |
|
JPM
Jpmorgan Chase Co
|
282.78 | 746.46B | 172.84B | 59.70B | -139.69B | 20.37 |
|
BAC
Bank Of America Corp
|
47.15 | 339.61B | 103.44B | 27.85B | 4.55B | 3.36 |
|
WFC
Wells Fargo Co
|
81.59 | 245.53B | 81.58B | 20.00B | 4.12B | 5.57 |
|
HSBC
Hsbc Holdings Plc Adr
|
61.57 | 208.50B | 72.00B | 20.72B | 153.10B | 5.45 |
|
RY
Royal Bank Of Canada
|
131.76 | 180.96B | 44.47B | 13.04B | 56.66B | 8.9892 |
Citigroup Inc Stock (C) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Initiated | TD Cowen | Hold |
| Jan-06-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-03-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Apr-04-24 | Reiterated | Evercore ISI | In-line |
| Mar-25-24 | Reiterated | Wells Fargo | Overweight |
| Mar-14-24 | Upgrade | Goldman | Neutral → Buy |
| Feb-14-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-30-24 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Jan-10-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-09-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-08-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-03-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-18-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Sep-07-23 | Initiated | HSBC Securities | Hold |
| Jul-18-23 | Upgrade | Odeon | Hold → Buy |
| Jul-10-23 | Downgrade | Societe Generale | Buy → Hold |
| Dec-08-22 | Initiated | Piper Sandler | Neutral |
| Oct-03-22 | Downgrade | Goldman | Buy → Neutral |
| Sep-06-22 | Downgrade | Odeon | Buy → Hold |
| May-27-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-28-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Mar-07-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-03-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Dec-15-21 | Upgrade | Odeon | Hold → Buy |
| Dec-10-21 | Resumed | UBS | Neutral |
| Dec-06-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
| Jun-16-21 | Reiterated | Credit Suisse | Outperform |
| Apr-05-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-29-21 | Downgrade | Edward Jones | Buy → Hold |
| Jan-21-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-06-21 | Initiated | Daiwa Securities | Buy |
| Jan-04-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-19-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Oct-15-20 | Downgrade | DZ Bank | Buy → Hold |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-18-20 | Downgrade | Odeon | Hold → Sell |
| Jul-17-20 | Downgrade | Odeon | Buy → Hold |
| Jul-08-20 | Initiated | Seaport Global Securities | Buy |
| Jul-07-20 | Upgrade | Societe Generale | Hold → Buy |
| Jun-09-20 | Downgrade | Standpoint Research | Buy → Hold |
| Jun-02-20 | Upgrade | Odeon | Hold → Buy |
| May-18-20 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-20-20 | Upgrade | Argus | Hold → Buy |
| Apr-14-20 | Upgrade | Societe Generale | Sell → Hold |
| Apr-01-20 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Feb-03-20 | Downgrade | Odeon | Buy → Hold |
| Jan-09-20 | Initiated | DA Davidson | Buy |
| Jan-06-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-20 | Reiterated | Goldman | Buy |
| Jul-26-19 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| May-30-19 | Upgrade | Goldman | Neutral → Buy |
| Feb-22-19 | Upgrade | Jefferies | Hold → Buy |
View All
Citigroup Inc Stock (C) Latest News
Citi Sees Gold Price Falling Below $3,000 While Middle East Tensions Growing - NAI500
Citigroup (C) Appoints Jonathan Moulds to Board of Directors - GuruFocus
Citi's $476 Billion Bank Bailout...What Happened？ - MSN
Citigroup Says Fed Cuts Rates 3 Times in 2025 – Grab These 7% Dividend Giants Now - AOL.com
Citigroup Appoints Jonathan Moulds as Independent Director - TipRanks
Citigroup (C) Appoints Jonathan Moulds to its Board - StreetInsider
Form 424B2 CITIGROUP INC - StreetInsider
Citi's 'accelerating' its AI strategy with new leaders. Here's how they're readying the firm for a new future. - Business Insider
IG Group’s Jonathan Moulds appointed as Citigroup non-exec director - FX News Group
IG Group’s Jonathan Moulds Joins Citigroup Board - TipRanks
Valaris (NYSE:VAL) Price Target Raised to $47.00 at Citigroup - MarketBeat
Morgan Stanley (MS): Citigroup Raises Price Target Amid Neutral Rating | MS Stock News - GuruFocus
Citigroup Issues Positive Forecast for Roku (NASDAQ:ROKU) Stock Price - MarketBeat
Seadrill (NYSE:SDRL) Given New $36.00 Price Target at Citigroup - MarketBeat
Morgan Stanley (NYSE:MS) Price Target Raised to $130.00 at Citigroup - MarketBeat
US Financial 15 Split Corp. Preferred Dividend Declared - GlobeNewswire Inc.
Smart Share Global (NYSE:EM) Given Neutral Rating at Citigroup - MarketBeat
Icon Solutions Ltd. announced that it has received funding from UBS Group AG, Citigroup Inc., NatWest Group plc - MarketScreener
CWA Asset Management Group LLC Has $4.93 Million Stock Position in Citigroup Inc. (NYSE:C) - MarketBeat
Citigroup Trims Lennar Price Target to $117 From $118, Neutral Rating Maintained - marketscreener.com
PSI Advisors LLC Lowers Position in Citigroup Inc. (NYSE:C) - MarketBeat
State of Alaska Department of Revenue Acquires 4,335 Shares of Citigroup Inc. (NYSE:C) - MarketBeat
Citigroup Downgrades Smart Share Global to Neutral From Buy, Adjusts Price Target to $1.25 From $1 - marketscreener.com
Clarius Group LLC Has $1.43 Million Stock Position in Citigroup Inc. (NYSE:C) - MarketBeat
Citigroup Adjusts Price Target on Morgan Stanley to $130 From $125, Maintains Neutral Rating - marketscreener.com
UK Stocks Are Favorite Geopolitical Hedge, Citi’s Manthey Says - Bloomberg
Citigroup Adjusts Price Target on TKO Group Holdings to $200 From $170, Maintains Buy Rating - MarketScreener
Icon Solutions Announces New Equity Investment From UBS, Additional Funding From Citi & Natwest - MarketScreener
Asio Capital LLC Invests $4.55 Million in Citigroup Inc. (NYSE:C) - MarketBeat
Morgan Stanley Maintains its Citigroup Inc. (C) Buy Rating - MSN
CMO Alex Craddock shares how Citigroup's marketing content strategy is evolving with new media and storytelling - Business Insider
Citi sees gold price falling below $3,000 as rally fades - Mining.com
Citigroup Adjusts Price Target on Simon Property Group to $170 From $185 - marketscreener.com
McCormick & Co (MKC): Citigroup Lowers Price Target to $77 | MKC Stock News - GuruFocus
Citigroup Cuts McCormick & Company, Incorporated (NYSE:MKC) Price Target to $77.00 - MarketBeat
Citigroup Initiates Coverage on Acumen Pharmaceuticals (ABOS) wi - GuruFocus
Citigroup Initiates Coverage on Protagonist Therapeutics (PTGX) with a 'Buy' Rating | PTGX Stock News - GuruFocus
Novavax (NVAX) Coverage Initiated with 'Sell' Rating by Citigrou - GuruFocus
Novavax (NVAX) Coverage Initiated with 'Sell' Rating by Citigroup | NVAX Stock News - GuruFocus
Citigroup (C) Plans $650M Note Redemption Aligned with Funding Strategy - GuruFocus
Citigroup announces cash redemption of $650M floating rate notes (C:NYSE) - Seeking Alpha
Citi regroups DCM leadership with internal promotions - GlobalCapital
Citigroup Adjusts Price Target on Constellation Brands to $170 From $190, Maintains Neutral Rating - marketscreener.com
Citigroup Initiates Arcellx at Buy With $110 Price Target - marketscreener.com
Citigroup Initiates Protagonist Therapeutics at Buy With $72 Price Target - marketscreener.com
Citigroup Adjusts Price Target on McCormick & Company to $77 From $80, Maintains Neutral Rating - marketscreener.com
Sagespring Wealth Partners LLC Purchases 6,282 Shares of Citigroup Inc. (NYSE:C) - MarketBeat
Thiel-Backed Fund Invests in Ex-Citi Banker’s Stablecoin Startup - Bloomberg
Citi calls time on gold’s rally due to slumping demand, Fed cuts - Mining Weekly
Iron Ore Extends Drop as Demand Concerns Rise, Citi Cuts Targets - Bloomberg
Citi Calls Time on Gold’s Rally Due to Slumping Demand, Fed Cuts - Bloomberg
Citigroup Inc Stock (C) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.30%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):